IRD
Opus Genetics, Inc. Common Stock
27 hedge funds and large institutions have $2.58M invested in Opus Genetics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
4
Closed
5
Calls
$64K
Puts
–
Net Calls
+$64K
Net Calls Change
+$49K
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$119K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$24K |
| 3 |
Jane Street
New York
|
+$19K |
| 4 |
BlackRock
New York
|
+$16.3K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$7.55K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$26K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$7.69K |
| 3 |
Bank of New York Mellon
New York
|
-$6.38K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
26
Group One Trading
Chicago,
Illinois
| – | -$6K | -81 | Closed |
|
|
27
Bank of America
Charlotte,
North Carolina
| – | -$1K | -15 | Closed |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| – | -$1K | -8 | Closed |
|